TCL Archive Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA May 23, 1986
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Phillip Sharp Selected Next MIT President; Montgomery Retires From SRI Administration February 23, 1990
TCL Archive U.S. Cancer Mortality Declines Overall; Incidence, Death, For 12 Cancers Rising June 8, 2001
